Areas of Focus
- Ion Channels
- Viruses
- Drug Discovery
- Cell Death
Work Experience
- 2018-09~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Associate Researcher
- 2016-07~2018-06 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Postdoctoral Researcher
- 2011-09~2016-06 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - PhD
Academic Background & Achievements
- 2011-09--2016-06 PhD: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Publications
- Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2, Xia Bingqing, 2023
- Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2, Xia Bingqing, 2023
- Mapping the Acetylamino and Carboxyl Groups on Glycans by Engineered & alpha;-Hemolysin Nanopores, Xia Bingqing, 2023
- Why is the SARS-CoV-2 Omicron variant milder?, Xia Bingqing, 2022
- Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates, Xia Bingqing, 2022
- SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target, Xia Bingqing, 2021
- Folded or Degraded in Endoplasmic Reticulum, Xia Bingqing, 2020
- Succinate-acetate permease from Citrobacter koseri is an anion channel that unidirectionally translocates acetate, Xia Bingqing, 2018
- Succinate-acetate permease from Citrobacter koseri is an anion channel that unidirectionally translocates acetate, Xia Bingqing, 2018
- MLKL forms cation channels, Xia Bingqing, 2016
- Bimodal voltage dependence of TRPA1: mutations of a key pore helix residue reveal strong intrinsic voltage-dependent inactivation, Xia Bingqing, 2013
Awards
- Chinese Academy of Sciences Youth Innovation Promotion Association Outstanding Member (2023)
- Shanghai Science and Technology Innovation Action Plan Star A (2022)
- Sanofi-Excellent Young Talent of Shanghai Institute of Biological Sciences, Chinese Academy of Sciences (2017)
